Pathological complete response (pCR) serves as a critical measure of the success of neoadjuvant chemotherapy (NAC) in breast cancer, directly influencing subsequent therapeutic decisions. With the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results